| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |